GOUT BECOMES OF AGE
Authors: JOHN H. TALBOTT
Journal: Annals of Internal Medicine (1955)

Editorial1 May 1955GOUT BECOMES OF AGEJOHN H. TALBOTTJOHN H. TALBOTTSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-42-5-1137 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIt is reassuring to note that gout has reached maturity during the past decade after an adolescence considerably longer than has been required for many other maladies. Evidence of maturity may be documented. Gout has been accorded equal status with diabetes mellitus and other recognized clinical entities on the cover ofMetabolism, a journal which made its appearance in 1953.1Also, in the initial issue of theJournal of Chronic Diseases,2Seegal identifies gout "as a chronic disorder of middle or late life, to be recognized early in life because of increased clinical awareness and improved diagnostic measures." This editorial...1 Metabolism, Grune and Stratton, New York, 1: 1, 1952. Google Scholar2 Seegal D: Some observations on the beginnings of chronic disease, J. Chr. Dis. 1: 90, 1955. CrossrefMedlineGoogle Scholar3 Vom Podagra B 1715. Google Scholar4 Viets HR: Boston Medical Library, Report of the librarian for 1952, New England J. Med. 249: 685, 1953. CrossrefMedlineGoogle Scholar5 KuzellSchaffarzickNauglerGaudinMankleBrown WCRWWEGEAB: Phenylbutazone (Butazolidin) in gout, Am. J. Med. 16: 212, 1954. CrossrefMedlineGoogle Scholar6 Bartels EC: Gout—now amenable to control, Ann. Int. Med. 42: 1, 1955. LinkGoogle Scholar7 Ungerleider HE: The internist and life insurance, Ann. Int. Med. 41: 124, 1954. LinkGoogle Scholar8 BishopTalbott CJH: Uric acid: its role in biological processes and the influence upon it of physiological, pathological and pharmacological agents, Pharmacol. Rev. 5: 3, 1953. Google Scholar9 BuzardBishopTalbott JACJH: The conversion of uric acid to allantoin in the normal and gouty human, J. Biol. Chem. 211: 559, 1954. CrossrefMedlineGoogle Scholar10 BenedictForshamStetten JDPDW: Metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid, J. Biol. Chem. 181: 183, 1949 CrossrefMedlineGoogle Scholar11 BishopGarnerTalbott CWJH: Pool size, turnover rate and rapidity of equilibration of injected isotopic uric acid in normal and pathological subjects, J. Clin. Investigation 30: 879, 1951. CrossrefMedlineGoogle Scholar12 BenedictForshamRocheSolowayStetten JDPHJSDW: The effect of salicylates and adrenocortocotropic hormone upon the miscible pool of uric acid in gout, J. Clin. Investigation 29: 1104, 1950. CrossrefMedlineGoogle Scholar13 FolinBerglundDerrick OHC: The uric acid problem; an experimental study of animals and man, including gouty subjects, J. Biol. Chem. 60: 361, 1924. CrossrefGoogle Scholar14 CoombsPecoraThorogoodConsolazioTalbott FSLJEWVJH: Renal function in patients with gout, J. Clin. Investigation 19: 525, 1940. CrossrefMedlineGoogle Scholar15 FriedmanByers MSO: Increased renal excretion of urate in young patients with gout, Am. J. Med. 9: 31, 1950. CrossrefMedlineGoogle Scholar16 GutmanYu ABTF: Current principles of management of gout, Am. J. Med. 13: 744, 1952 CrossrefMedlineGoogle Scholar17 BenedictRocheYuBienGutmanStetten JDMTFEJABDW: Incorporation of glycine nitrogen into uric acid in normal and gouty man, Metabolism 1: 3, 1952. MedlineGoogle Scholar18 TalbottCoombs JHFS: Metabolic studies on patients with gout, J. A. M. A. 110: 1977, 1938. CrossrefGoogle Scholar19 ShetlarPayneBullockPatrickHellbaumIshmael MRRWJADRAAWK: Comparative studies of serum polysaccharides in rheumatoid arthritis and degenerative joint disease, J. Clin. Investigation 32: 1208, 1953. CrossrefMedlineGoogle Scholar20 ZiffSimsonScullSmithShattonMainland MJEAJD: Aminotripeptidase content of synovial fluid in arthritis diseases, J. Clin. Investigation 34: 27, 1955. CrossrefMedlineGoogle Scholar21 TalbottNorcrossLockie JHBMLM: The clinical and metabolic effects of Benemid in patients with gout, Tr. A. Am. Physicians 64: 372, 1951. MedlineGoogle Scholar22 Diet and the metabolic defect in gout, Nutrition Reviews 11: 107, 1953. MedlineGoogle Scholar23 KittredgeDown WER: The role of gout in the formation of urinary calculi, J. of Urol. 67: 841, 1952. CrossrefMedlineGoogle Scholar24 BogerSmith WPRT: The role of probenecid in the therapy of gout, Svenska Lakartidningen, 51: 2021, 1954. MedlineGoogle Scholar25 BogerStrickland WPSC: Probenecid (Benemid), its uses and side effects in 2502 patients, Arch. Int. Med. 95: 83, 1955. CrossrefGoogle Scholar26 Talbott JH: Gout and gouty arthritis, Modern Medical Monographs, Grune and Stratton, New York, 1953. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByRHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (TWELFTH RHEUMATISM REVIEW)* Part IICHARLEY J. SMYTH, M.D., F.A.C.P., JOSEPH J. BUNIM, M.D., F.A.C.P., WILLIAM S. CLARK, M.D., F.A.C.P., DARRELL C. CRAIN, M.D., F.A.C.P., FELIX E. DEMARTINI, M.D., IVAN F. DUFF, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P. (C), MAX M. MONTGOMERY, M.D., F.A.C.P., BERNARD M. NORCROSS, M.D., F.A.C.P., HOWARD F. POLLEY, MARIAN W. ROPES, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P.Some Unsolved Problems of GoutSome observations on 520 gouty patients 1 May 1955Volume 42, Issue 5Page: 1137-1146KeywordsAdolescentsDiabetes mellitusGout Issue Published: 1 May 1955 PDF DownloadLoading ...